Discover
MLAB
Mesa Laboratories, Inc.
106.04
1 x 105.90
9 x 106.23
bid
ask
-
7.16
6.33%
1 @ 04:00 PM
106.04 +0.00 (0.00%)
| Ytd | 35.08% | |
| 1y | 56.19% |
105.24
day range
114.09
59.53
52 week range
113.20
| Open | 113.09 | Prev Close | 113.20 | Low | 105.24 | High | 114.09 | Mkt Cap | 593.39M |
| Vol | 160.83K | Avg Vol | 201.83K | EPS | 9.91 | P/E | 10.70 | Forward P/E | 18.42 |
| Beta | 0.86 | Short Ratio | 3.64 | Inst. Own | 91.88% | Dividend | 0.64 | Div Yield | 0.48 |
| Ex Div Date | 11-29 | Earning | 08-10 | 50-d Avg | 100.86 | 200-d Avg | 90.83 | 1yr Est | 133.33 |
| Income Statement | |||
| Total Revenue | 60.14M | ||
| Revenues (USD) | 60.14M | ||
| Cost of Revenue | 21.13M | ||
| Gross Profit | 39.01M | ||
| Operating Expenses | 31.98M | ||
| Research and Development Expense | 4.72M | ||
| Selling, General and Administrative Expense | 27.26M | ||
| Operating Income | 7.03M | ||
| Interest Expense | 2.36M | ||
| Income Tax Expense | 1.52M | ||
| Net Income | 2.83M | ||
| Net Income Common Stock | 2.83M | ||
| Net Income Common Stock (USD) | 2.83M | ||
| Consolidated Income | 2.83M | ||
| Earnings per Basic Share | 0.50 | ||
| Earnings per Basic Share (USD) | 0.50 | ||
| Earnings per Diluted Share | 0.49 | ||
| Dividends per Basic Common Share | 0.16 | ||
| Earning Before Interest & Taxes (EBIT) | 6.72M | ||
| Earning Before Interest & Taxes (USD) | 6.72M | ||
| Weighted Average Shares | 5.66M | ||
| Weighted Average Shares Diluted | 5.76M | ||
| Balance Sheet | |||
| Cash and Equivalents | 30.70M | ||
| Cash and Equivalents (USD) | 30.70M | ||
| Trade and Non-Trade Receivables | 34.41M | ||
| Current Assets | 102.85M | ||
| Property, Plant & Equipment Net | 30.09M | ||
| Total Assets | 419.22M | ||
| Debt Current | 5.63M | ||
| Total Debt | 158.72M | ||
| Current Liabilities | 57.32M | ||
| Debt Non-Current | 153.10M | ||
| Total Liabilities | 230.46M | ||
| Accumulated Retained Earnings (Deficit) | -183.80M | ||
| Accumulated Other Comprehensive Income | -4.19M | ||
| Shareholders Equity | 188.76M | ||
| Shareholders Equity (USD) | 188.76M | ||
| Assets Non-Current | 316.38M | ||
| Total Debt (USD) | 158.72M | ||
| Deferred Revenue | 14.52M | ||
| Goodwill and Intangible Assets | 264.44M | ||
| Inventory | 27.23M | ||
| Liabilities Non-Current | 173.14M | ||
| Trade and Non-Trade Payables | 7.46M | ||
| Tax Assets | 1.49M | ||
| Tax Liabilities | 20.05M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 5.65M | ||
| Net Cash Flow from Financing | -10.50M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 3.77M | ||
| Capital Expenditure | -559.00K | ||
| Issuance (Repayment) of Debt Securities | -8.66M | ||
| Payment of Dividends & Other Cash Distributions | -884.00K | ||
| Net Cash Flow from Investing | -559.00K | ||
| Net Cash Flow from Operations | 14.74M | ||
| Effect of Exchange Rate Changes on Cash | 88.00K | ||
| Share Based Compensation | 2.36M | ||